On this page
Grace Colon
Insider
First SEC filing: June 11, 2026 · Latest: June 11, 2026
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 9, 2026 | VYGR | A | 30,000 | · | · | · Direct | · | Acquired | (price as of 2026-10-05) |
| June 3, 2025 | VYGR | A | 24,000 | · | · | 24,000 Direct | · | Acquired | (price as of 2026-10-05) |
| June 5, 2024 | VYGR | A | 24,000 | · | · | 24,000 Direct | · | Acquired | (price as of 2026-10-05) |
| June 16, 2023 | CDNA | A | 29,136 | · | · | 29,136 Direct | · | Acquired | (price as of 2026-10-05) |
| June 16, 2023 | CDNA | A | 18,844 | · | · | 23,708 Direct | +387.42% | Acquired | (price as of 2026-10-05) |
| June 6, 2023 | VYGR | A | 22,000 | · | · | 22,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 1, 2023 | VYGR | A | 44,000 | · | · | 44,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 10, 2022 | CDNA | S | 2,521 | $24.81 | $62,546 | 4,864 Direct | -34.14% | Disposed | 176.4% (price as of 2026-10-05) |
| June 16, 2022 | CDNA | A | 7,606 | · | · | 7,606 Direct | · | Acquired | (price as of 2026-10-05) |
| June 16, 2022 | CDNA | A | 4,863 | · | · | 7,385 Direct | +192.82% | Acquired | (price as of 2026-10-05) |
| May 11, 2022 | CDNA | S | 5,179 | $23.01 | $119,169 | 2,522 Direct | -67.25% | Disposed | 198.0% (price as of 2026-10-05) |
| March 9, 2022 | CDNA | S | 1,393 | $34.56 | $48,142 | 7,701 Direct | -15.32% | Disposed | 98.4% (price as of 2026-10-05) |
| June 16, 2021 | CDNA | A | 1,812 | · | · | 1,812 Direct | · | Acquired | (price as of 2026-10-05) |
| June 16, 2021 | CDNA | A | 1,127 | · | · | 9,094 Direct | +14.15% | Acquired | (price as of 2026-10-05) |
| June 18, 2020 | CDNA | A | 4,978 | $31.35 | $156,060 | 4,978 Direct | · | Acquired | 118.8% (price as of 2026-10-05) |
| June 18, 2020 | CDNA | A | 3,190 | · | · | 7,967 Direct | +66.78% | Acquired | (price as of 2026-10-05) |
| Jan. 2, 2020 | CDNA | A | 326 | · | · | 4,777 Direct | +7.32% | Acquired | (price as of 2026-10-05) |
| Oct. 1, 2019 | CDNA | A | 270 | · | · | 4,451 Direct | +6.46% | Acquired | (price as of 2026-10-05) |
| July 1, 2019 | CDNA | A | 6,569 | · | · | 6,569 Direct | · | Acquired | (price as of 2026-10-05) |
| July 1, 2019 | CDNA | A | 4,181 | · | · | 4,181 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 9, 2026 | VYGR | Stock Option (Right to Buy) | Common Stock | $3.43 | June 9, 2036 | 30,000 | Acquired |
| June 3, 2025 | VYGR | Stock Option (Right to Buy) | Common Stock | $3.28 | June 3, 2035 | 24,000 | Acquired |
| June 5, 2024 | VYGR | Stock Option (Right to Buy) | Common Stock | $8.70 | June 5, 2034 | 24,000 | Acquired |
| June 16, 2023 | CDNA | Common Stock | Common Stock | $7.96 | June 16, 2033 | 29,136 | Acquired |
| June 6, 2023 | VYGR | Stock Option (Right to Buy) | Common Stock | $12.57 | June 6, 2033 | 22,000 | Acquired |
| Jan. 1, 2023 | VYGR | Stock Option (Right to Buy) | Common Stock | $6.10 | Jan. 1, 2033 | 44,000 | Acquired |
| June 16, 2022 | CDNA | Common Stock | Common Stock | $20.56 | June 16, 2032 | 7,606 | Acquired |
| June 16, 2021 | CDNA | Stock Option (right to buy) | Common Stock | $88.70 | June 16, 2031 | 1,812 | Acquired |
| June 18, 2020 | CDNA | Stock Option (right to buy) | Common Stock | $31.35 | June 18, 2030 | 4,978 | Acquired |
| July 1, 2019 | CDNA | Employee Stock Option (right to buy) | Common Stock | $35.87 | July 1, 2029 | 6,569 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).